Acute coronary syndromes clinical care standard indicators: 3a-Proportion of patients with ST-segment-elevation myocardial infarction (STEMI) receiving fibrinolysis or percutaneous coronary intervention (PCI), 2019-
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Indicator |
Short name: | Indicator 3a-Proportion of STEMI patients receiving fibrinolysis or PCI |
METEOR identifier: | 719388 |
Registration status: | Australian Commission on Safety and Quality in Health Care, Qualified 17/09/2019 |
Description: | Proportion of patients with ST-segment-elevation myocardial infarction (STEMI) presenting within 12 hours of symptom onset receiving fibrinolysis or percutaneous coronary intervention (PCI). |
Indicator set: |
Collection and usage attributes | |||||||||
Computation description: | Both the numerator and the denominator include patients with STEMI. Both the numerator and denominator exclude patients with a diagnosis of left bundle branch block (LBBB). This is where Episode of care—principal diagnosis, code (ICD-10-AM 11th edn) ANN{.N[N]} or Episode of care—additional diagnosis, code (ICD-10-AM 11th edn) ANN{.N[N]} is one of the following:
For the numerator, patients undergoing PCI include those for which one of the following Episode of admitted patient care—procedure, code (ACHI 11th edn) NNNNN-NN is recorded:
Alternatively, for hospitals collecting the Acute coronary syndrome (clinical) National best practice data set, the data element Person—percutaneous coronary intervention procedure type, code N can be used, where there is a value of 1 Balloon angioplasty only, 2 Bare metal stent implantation or 3 Drug-eluting stent implantation recorded. The numerator also includes patients who are administered fibrinolytic drugs. These are not coded using the Australian Classification of Health Interventions (ACHI). However, for hospitals using the Acute coronary syndrome (clinical) National best practice data set, the data element Person—fibrinolytic drug administered, code N can be used to indicate fibrinolytic drug therapy, where the values are one of the following:
The denominator excludes patients for whom PCI and fibrinolysis are contraindicated (where the contraindication is documented in their medical record). (For hospitals using the Acute coronary syndrome (clinical) National best practice data set, contraindication for fibrinolytic therapy can be identified using the data element Person—reason for non prescription of pharmacotherapy, code N, where a value of 2 'Contraindicated' is recorded.) Contraindications may include advance care directives, being on a palliative care pathway, and clinical judgement, subject to discussion with patients, family and carers. Presented as a percentage. | ||||||||
---|---|---|---|---|---|---|---|---|---|
Computation: | (Numerator ÷ denominator) x 100 | ||||||||
Numerator: | Number of patients with STEMI arriving at the emergency department or being attended to by ambulance officers within 12 hours of symptom onset, who receive fibrinolysis or PCI. | ||||||||
Denominator: | Number of patients with STEMI arriving at the emergency department or being attended to by ambulance officers within 12 hours of symptom onset. | ||||||||
Representational attributes | |||||||||
Representation class: | Percentage | ||||||||
Data type: | Real | ||||||||
Unit of measure: | Episode | ||||||||
Format: | N[NN] | ||||||||
Source and reference attributes | |||||||||
Submitting organisation: | Australian Commission on Safety and Quality in Health Care |